Month:

February 2019

Antibiotic Stewardship Update: Restrictions on Fluoroquinolones

The Antibiotic Stewardship team requests your participation in Englewood Hospital’s most recent Antibiotic Stewardship initiative: the restriction for both oral and injectable fluoroquinolones. Fluoroquinolone use (i.e. levofloxacin, ciprofloxacin, moxifloxacin, ofloxacin) has significantly and consistently been associated with the development of Clostridium difficile infections (CDI) and extended-spectrum beta-lactamase Enterobacteriaceae such as E. Coli. There is also […]

New Treatment for Severe Carotid Artery Disease

Englewood Health is one of the first hospitals in New Jersey to offer a new, minimally invasive procedure to treat severe carotid artery disease, a condition in which plaque builds up inside the arteries and can lead to a stroke. The procedure, called transcarotid artery revascularization (TCAR), is unique in that blood flow is temporarily […]

CEO Town Hall Recap

Two weeks ago, Warren Geller held the annual CEO Town Hall meetings for medical staff, employees, and volunteers, where he spoke about where we are today and where we are going. Watch the video on YouTube Watch the video on the ePortal

EHPN News in Brief: February 13, 2019

From Dr. Stephen Brunnquell, EHPN President Contract Signed with Real Estate Adviser: I am delighted to report that EHPN has a contract with CBRE, a very large, prestigious real estate firm. We started a Master Facility Planning process last spring and this is its result. CBRE will immediately take all our leases and create a master […]